Quick Answer
Lexeo Therapeutics, Inc. reported Revenue (ASC 606) of $654.0 thousand for fiscal year 2022.
Lexeo Therapeutics, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2022 | $654.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $531.0K | — | — |
- The most recent figure is from Lexeo Therapeutics, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 11, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: